We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+8.74%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$787M
AUM Growth
+$57.8M
Cap. Flow
+$1.72M
Cap. Flow %
0.22%
Top 10 Hldgs %
72.39%
Holding
62
New
3
Increased
5
Reduced
6
Closed
2

Top Buys

Rank Stock Value
1
BNY
Bank of New York Mellon
BNY
+$3.84M
2
WFC icon
Wells Fargo
WFC
+$675K
3
USB icon
US Bancorp
USB
+$503K
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$472K
5
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$106K

Top Sells

Rank Stock Value
1
AKTX
Akari Therapeutics
AKTX
+$2.61M
2
IBM icon
IBM
IBM
+$400K
3
ALPN
Alpine Immune Sciences Inc
ALPN
+$366K
4
KHC icon
Kraft Heinz
KHC
+$200K
5
TGTX icon
TG Therapeutics
TGTX
+$195K

Sector Composition

Rank Sector Weight
1 Financials 45.64%
2 Healthcare 19.26%
3 Industrials 7.41%
4 Materials 6.59%
5 Technology 4.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKTX
51
Akari Therapeutics
AKTX
$13.5M
$156K 0.02%
112
-1,763
-94% -$2.61M
ALDX icon
52
Aldeyra Therapeutics
ALDX
$91.1M
$148K 0.02%
20,020
-20,000
-50% -$129K
BDSI
53
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$93K 0.01%
+25,000
New +$106K
ALPN
54
DELISTED
Alpine Immune Sciences Inc
ALPN
$92K 0.01%
10,445
-40,000
-79% -$366K
CRVS icon
55
Corvus Pharmaceuticals
CRVS
$1.24B
$80K 0.01%
19,959
-41,000
-67% -$164K
ADMA icon
56
ADMA Biologics
ADMA
$2.22B
$72K 0.01%
+30,075
New +$82.5K
AMRN
57
Amarin Corp
AMRN
$296M
$63K 0.01%
+750
New +$89.9K
IBM icon
58
IBM
IBM
$225B
– –
-3,462
Closed -$400K
TGTX icon
59
TG Therapeutics
TGTX
$7.64B
– –
-10,000
Closed -$195K
1 2
3

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q3 2020 Portfolio in Review

As of Q3 2020, Hikari Power held 62 positions worth $787M, up 7.9% from $729M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Hikari Power's Q3 2020 filing shows 3 new, 5 increased, 6 reduced and 2 closed positions. Its largest new stake was BioDelivery Sciences International, Inc.: 25,000 shares worth $93K. The largest sale was Akari Therapeutics, an estimated $2.61M.

By sector, the portfolio is most concentrated in Financials at 46% of assets, up from 44% a quarter earlier, followed by Healthcare and Industrials.

  • Hikari Power's largest Q3 2020 buy was BioDelivery Sciences International, Inc.: 25,000 shares worth $93K.
  • Hikari Power added most to Bank of New York Mellon in Q3 2020, an estimated $3.84M increase.
  • Hikari Power's biggest Q3 2020 reduction was Akari Therapeutics, cutting an estimated $2.61M.
  • Hikari Power fully exited IBM in Q3 2020, selling an estimated $400K.
  • Hikari Power's ten largest holdings make up 72% of its $787M portfolio in Q3 2020.
  • Hikari Power opened 3 new positions and closed 2 in Q3 2020.
  • Hikari Power's portfolio value rose 7.9% quarter-over-quarter to $787M.

Based on Hikari Power's 13F filing for Q3 2020, filed 8 Oct 2020.